Popular Articles
Today Week Month Year


Joe Biden diagnosed with aggressive PROSTATE CANCER
By Belle Carter // May 21, 2025

  • Former President Joe Biden, 82, has been diagnosed with aggressive prostate cancer (Gleason 9, Grade Group 5). His cancer is hormone-sensitive, allowing for potential management.
  • Previously treated for basal cell carcinoma in 2023, Biden’s health remains a public topic amid debates over his fitness for office, as highlighted in the book "Original Sin."
  • Political figures, including President Donald Trump and former Vice President Kamala Harris, have expressed concern and admiration for Biden’s resilience.
  • Inspired by his son Beau's 2015 death from brain cancer, Biden launched Cancer Moonshot to halve cancer deaths in 25 years.
  • There is no official plan for Biden's cancer treatment yet, but experts suggest hormone therapy, possibly with chemo/radiation. Advances offer hope for extended survival in advanced cases.

Former U.S. President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones.

Biden's diagnosis came after he experienced urinary symptoms and a prostate nodule was detected during a routine examination. His office stated that the cancer has a Gleason score of 9 (Grade Group 5), indicating it is among the most aggressive forms of the disease. However, the cancer is hormone-sensitive, which offers a glimmer of hope for effective management. (Related: Biden's prostate nodule revelation coincides with release of explosive book detailing cognitive decline and wheelchair discussions.)

Biden's health has been a subject of public interest for years. In 2023, he was successfully treated for basal cell carcinoma, a common form of skin cancer, after a lesion was removed from his chest. This latest diagnosis marks his second battle with cancer, adding to the list of health challenges he has faced in recent years.

The former president's health has been a topic of debate, especially after the release of the book "Original Sin" by journalists Jake Tapper and Alex Thompson. The book alleges a White House cover-up of Biden's declining health and cognitive abilities, citing accounts of memory lapses and incoherent speeches. Despite these allegations, Biden has consistently rejected the notion that he is unfit to serve.

The announcement has elicited a wave of support from political figures across the spectrum. President Donald Trump, who defeated Biden's vice-president, Kamala Harris, in the 2024 election, expressed his concern on Truth Social. "Melania and I are saddened to hear about Joe Biden's recent medical diagnosis," he wrote. "We extend our warmest and best wishes to Jill Biden and the family, and we wish Joe a fast and successful recovery."

Harris also shared her thoughts on X, saying, "Joe is a fighter – and I know he will face this challenge with the same strength, resilience and optimism that have always defined his life and leadership."

The "Cancer Moonshot" initiative

Biden's diagnosis comes at a time when he has been a vocal advocate for cancer research and treatment. During his presidency, he launched the "cancer moonshot" initiative, aiming to halve the cancer death rate over the next 25 years. This initiative was deeply personal for Biden, as it was inspired by his late son Beau, who died of brain cancer in 2015.

The cancer moonshot has led to significant advancements in cancer research, particularly in the field of prostate cancer. According to the American Cancer Society, prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States.

Prostate cancer specialists have noted that recent advances in diagnosis and treatment have dramatically improved the prognosis for patients with advanced disease. Dr. Daniel W. Lin, a prostate cancer specialist at the University of Washington, stated, "Life is measured in years now, not months."

Dr. Judd Moul, a prostate cancer expert at Duke University, added that men with prostate cancer that has spread to their bones can live for many years with current treatments.

"A man like Mr. Biden, in his 80s, could hopefully pass away from natural causes and not from prostate cancer," he said.

Biden's office has not yet announced a specific treatment plan, but experts suggest that the former president will likely undergo a combination of therapies. The first line of treatment for hormone-sensitive prostate cancer is to cut off the testosterone that feeds the cancer. This can be achieved through injections or pills that block testosterone production.

In addition to hormone therapy, patients may receive chemotherapy or radiation therapy, depending on the extent of the cancer. Dr. Lin noted that there are also new drugs available that can be used if initial treatments fail.

Head over to JoeBiden.news for more stories about the 46th U.S. president.

Watch the video below that talks about why Biden was not fit to be in office for a second term.

This video is from the TrendingNews channel on Brighteon.com.

More related stories:

Former Biden aide admits White House 'gaslit' public over president's cognitive decline.

Biden's dietary guidelines under fire: How political agendas are undermining American health

Biden says he might reconsider dropping out if his doctors advise that a medical condition warrants it.

Sources include:

RT.com

TheGuardian.com

NYTimes.com

Brighteon.com


0 Comments
Please sign in with your Brighteon account to leave comments
Learn more about our new comment system.
Sign Up

Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.